Sat, Feb 29, 2020
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Private Equity Strategies

Dealmakers Q&A: MedMen eye second fund

Friday, September 29, 2017

By: Bailey McCann, Private Equity Strategies

Los Angeles, California-based cannabis-focused investment firm MedMen is eying its second fund. The firm is targeting $250 million for investments in cannabis assets.

MedMen's investor base is largely high net worth individuals and family offices, but the firm has also had some institutional interest. MedMen partnered with Chicago-based Wicklow Capital, a venture capital firm, for investments from its first fund which closed on just under $100 million earlier this year. Wicklow Capital is backed by Dan Tierney, the co-founder and former board member of GETCO, a Chicago-based high-frequency trading firm, now known as KCG Holdings following GETCO's acquisition of Knight Capital in 2013. MedMen typically invests between $1-40 million per transaction and made seven investments from its debut fund.

Unlike other cannabis industry investors that are focused on investing in existing consumer distributors, MedMen invests in raw assets. The firm is looking for opportunities to buy licenses or cannabis assets that they can then turn into an enterprise. MedMen operates by using a management holding company model, so they are the owners of each entity in the portfolio, rather than simply investing in several companies.

"We made a strategic decision to be very hands-on with development," MedMen co-Chairman and Partner, Chris Leavy tells Private Equity Strategies. Leavy oversees the investment strategy for the firm. Prior to joining MedMen, Leavy spent more than two decades on Wall Street, holding senior management roles at Morgan Stanley, OppenheimerFunds, and BlackRock.

According to Leavy, the development model MedMen uses is more resource intensive, but it allows the firm to be a prime mover in the still nascent industry. "We are working on everything from regulatory, to site selection, to bringing in people with relevant experience," he explains. "Many people look at us as a pot business, but we are largely working with experts from other fields including agriculture, chemistry, consumer marketing, finance. We are creating a new industry."

MedMen has an established presence in states that allow medical marijuana and is expanding its footprint into emerging medical markets including Massachusetts, New York, and Nevada.

In some ways, the firm operates like a large mid-market specialist private equity manager. Because of the focus on a single industry, Leavy and the investment team can take advantage of common private equity scaling practices like group purchasing, group marketing, and supply chain optimization. For Leavy, that model is key to MedMen's growth prospects because he says, it creates standardization and opportunity in an otherwise inefficient and fragmented market. "We're still early enough into the development of the industry that people are trying a lot of different models," he says. "This isn't available in every state. So if we can come in and build scale, there is opportunity for us there."

 
This article was published in Opalesque's Private Equity Strategies our monthly research update on the global private equity landscape including all sectors and market caps.
Private Equity Strategies
Private Equity Strategies
Private Equity Strategies


Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Legal: Philip Falcone sued over alleged $65.8m default, Warhol painting[more]

    From Bloomberg: Former Harbinger Capital hedge fund manager Philip Falcone was accused in a New York lawsuit of defaulting on $65.8 million in loans and violating the terms of lending agreements by selling two paintings used as collateral, including one by Andy Warhol. Melody Business Finance LL

  2. U.S.: Second round of layoffs to hit TIAA's shuttered OCIO business this week, Capital buffers edged lower at systemic US banks in 2019[more]

    Second round of layoffs to hit TIAA's shuttered OCIO business this week From Institutional Investor: A second round of layoffs in TIAA's outsourced chief investment officer business is slated to take place this week, according to one former staffer. TIAA announced in November that it wa

  3. US-based micro venture capital funds raise a record amount of capital in 2019[more]

    Laxman Pai, Opalesque Asia: US-based micro venture capital funds (sized at $100mn or less) had another record-breaking year in 2019, said a report. Managers of micro funds surpassed the $8.3bn raised in 2018 with $8.4bn secured through 282 fund closures, according to the report by Preqin and t

  4. Tech: Privacy study: Brave browser smacks down Chrome, Firefox & Safari, How AI can bring new insight to private equity deals[more]

    Privacy study: Brave browser smacks down Chrome, Firefox & Safari From Coin Telegraph: A privacy expert who compared some of the most popular browsers on the market reached an unambiguous conclusion: Brave trumps competition. Trinity College Dublin's chair of computer systems, Dr. D

  5. Investing: How hedge funds were positioned for the market selloff, Hedge fund billionaire Jim Simons is betting millions, Billionaire Ken Griffin pulls the trigger on 3 "strong buy" stocks, Ackman still likes Chipotle, says sold shares to manage portfolio, EQT Corp sells half its stake in pipeline operator, strikes rate relief deal[more]

    How hedge funds were positioned for the market selloff From Institutional Investor: A look at the market exposure levels of funds including Tiger Global, Greenlight, Third Point and Horseman. Were hedge funds prepared for the stock market's sharp selloff? While their results won't